glp 1 gut microbiota The Interplay Between GLP-1-Based Therapies, the Microbiome, and MASLD/MASH in Type 2 Diabetes Mellitus: A Narrative Review Metabolic and gut microbiome changes
Description
doi: 10.1038/379069a0 72 Tang-ChristensenMLarsenPJGkeRFink-JensenAJessopDSMllerMet al
doi:10.2337/dc10-1393 103
Do GLP-1 patches contain real semaglutide or tirzepatide
Common side effects include mild nausea, constipation, or reduced appetite in the first weeksside effects that typically fade as your body adjusts
This has been expanded to weight-loss drugs being added to the package for those who qualify with a BMI higher than 30, along with other health parameters, as assessed by a medical expert
